Keith Valentine - Jan 5, 2023 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
President & CEO, Director
Signature
/s/ Patrick Keran, attorney-in-fact
Stock symbol
OFIX
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 05:50 PM
Previous filing
Jan 3, 2023
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +141K +54.18% $0.00 400K Jan 5, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OFIX Employee Stock Option (Right to Buy) Award $0 +338K $0.00 338K Jan 5, 2023 Common Stock 338K $20.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.
F2 Includes 260,896 unvested restricted stock units.
F3 The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.